Related Experiment Video
Updated: Jan 7, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Anticoagulation-Related Dilemma: A Thrombocytopenic Patient With Numerous Thrombogenic Risk Factors
Timothy Johnson1, Jennifer Trube1, Juan O Rodriguez-Padilla1
1Internal Medicine, Lakeland Regional Health, Lakeland, USA.
Managing anticoagulation in thrombocytopenic patients with high thrombotic risk is challenging due to lack of guidelines. This case highlights the need for individualized clinical judgment when balancing bleeding and clotting risks.
Area of Science:
- Internal Medicine
- Cardiology
- Oncology
Background:
- Anticoagulation is typically withheld in severe thrombocytopenia, posing challenges in patients with multiple thrombotic risks.
- Clinical decision-making is complex due to fluctuating platelet levels and the absence of clear guidelines.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

